Michael Zasloff
Michael A. Zasloff | |
|---|---|
| Born | February 7, 1946 New York City, U.S. |
| Alma mater | Columbia College (New York), New York University Grossman School of Medicine |
| Known for | Discovery of antimicrobial peptides (magainins); development of squalamine |
| Awards | Kilby Award (1994); Solomon Berson Award (1998); Doctor of Science, honoris causa, Georgetown University (2012) |
| Scientific career | |
| Fields | Immunology, Pediatrics, Biotechnology |
| Institutions | National Institutes of Health, University of Pennsylvania, Georgetown University |
Michael Alan Zasloff (born February 7, 1946) is an American physician–scientist, immunologist, and biotechnology entrepreneur. He is best known for discovering antimicrobial peptides in amphibians, particularly the magainins, and for developing the shark-derived compound squalamine as a potential therapy for viral infections and Parkinson's disease. Zasloff is Professor of Pediatrics and Surgery at Georgetown University School of Medicine and serves as Scientific Director of the MedStar Georgetown Transplant Institute .